SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001144204-12-041749
Filing Date
2012-07-30
Accepted
2012-07-30 17:25:28
Documents
1
Group Members
DR. JAMES I. HEALYDR. MICHAEL F. POWELLERIC P. BUATOISSOFINNOVA MANAGEMENT VII, L.L.C.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D v319728_sc13d.htm SC 13D 122512
  Complete submission text file 0001144204-12-041749.txt   124217
Mailing Address 2800 SAND HILL ROAD SUITE 150 MENLO PARK CA 94025
Business Address 2800 SAND HILL ROAD SUITE 150 MENLO PARK CA 94025 650-681-8420
SOFINNOVA VENTURE PARTNERS VII L P (Filed by) CIK: 0001380734 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 89 HEADQUARTERS PLAZA NORTH 14TH FLOOR MORRISTOWN NJ 09760
Business Address 89 HEADQUARTERS PLAZA NORTH 14TH FLOOR MORRISTOWN NJ 09760 973-993-4867
Durata Therapeutics, Inc. (Subject) CIK: 0001544116 (see all company filings)

IRS No.: 871247903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-86923 | Film No.: 12994597
SIC: 2834 Pharmaceutical Preparations